Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer-Reference-Cited by-同舟云学术

Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer

Published:2002-06-14 Issue:7 Volume:9 Page:613-623
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Lamers Cor H J,Willemsen Ralph A,Luider Barbara A,Debets Reno,Bolhuis Reinder L H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700477.pdf

Reference43 articles.

1. Rosenberg SA, Yannelli J, Yang J et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 J Natl Cancer Inst 1994 86: 1159–1166

2. Falkenburg JH, Wafelman AR, Joosten P et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes Blood 1999 94: 1201–1208

3. Lanzavecchia A, Scheidegger D . The use of hybrid hybridomas to target human cytotoxic T lymphocytes Eur J Immunol 1987 17: 105–111

4. Van Dijk J, Warnaar SO, Van Eendenburg JDH et al. Induction of tumour cell lysis by bi-specific monoclonal antibodies recognizing renal cell carcinoma and CD3 antigen Int J Cancer 1989 43: 344–349

5. Mezzanzanica D, Garrido MA, Neblock DS et al. Human T lymphocytes targeted against an established human ovarian carcinoma with a bi-specific F(ab′)2 antibody prolong host survival in a murine xenograft model Cancer Res 1991 5: 5716–5721

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation;Clinical and Experimental Medicine;2022-11-25

2. Recent advances in the production, reprogramming, and application of CAR-T cells for treating hematological malignancies;Life Sciences;2022-11

3. Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy;Blood Cancer Discovery;2021-08-03

4. Non-viral transfection technologies for next-generation therapeutic T cell engineering;Biotechnology Advances;2021-07

5. Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies;Hematology, Transfusion and Cell Therapy;2020-04